Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 423.42% to $3.59 per share on May 12

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q1'25

Est.

$3.59

Q4'24

Missed

by $0.92

Q3'24

Beat

by $0.31

Q2'24

Beat

by $0.38

Q1'24

Beat

by $0.06

The last earnings report on March 06 showed earnings per share of -111 cents, missing the estimate of -18 cents. With 85.25K shares outstanding, the current market capitalization sits at 330.05M.

View a ticker or compare two or three

Compare

ARCT